Immune Checkpoint Inhibitor Therapy for Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndromes: A Single-Center Experience

This article has no abstract
Epistemonikos ID: 7759144fc45d2ca9a6e8af40d23d1d8f84ff1b83
First added on: Feb 11, 2025